Traffic data pioneer Inrix to be acquired by Allstate's Arity after more than two decades
Seattle-area traffic data pioneer Inrix is selling substantially all of its assets to Arity, a mobility data subsidiary of Allstate.
ALL - The Allstate Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$266.43
DETAILS
HIGH:
$319.00
LOW:
$221.00
MEDIAN:
$265.50
CONSENSUS:
$266.43
UPSIDE:
7.48%
Stock News
Here's Why Allstate (ALL) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
September 2026 Monthly Release
NORTHBROOK, Ill., Oct. 15, 2026 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) today announced estimated catastrophe losses for the month of September of $220 million or $173 million, after-tax.
The Allstate Corporation $ALL Stock: Krilogy Financial LLC Raises Holdings
Krilogy Financial LLC grew its stake in shares of The Allstate Corporation (NYSE: ALL) by 106.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,754 shares of the insurance provider's stock after purchasing an additional 5,552 shares during the quarter.
Berkshire Hathaway vs. Allstate: Which Insurance Stock Has an Edge?
Disciplined pricing, rising climate-related risks and accelerating digital transformation are expected to shape the insurance industry's outlook in 2026. While growing catastrophe exposure remains a concern, prudent underwriting and pricing strategies should support profitability.
Allstate (ALL) Ascends While Market Falls: Some Facts to Note
Allstate (ALL) closed at $232.6 in the latest trading session, marking a +1.38% move from the prior day.
Allstate supports customers after Hurricane Isaias
Allstate helps customers file claims and navigate recovery, with additional in-person support at five mobile claims centers in Alabama and Florida Key takeaways File a claim anytime: Customers can file online, through the Allstate app, by calling 1-800-54-STORM (1-800-547-8676) or by contacting an Allstate agent. Get help in person: Five mobile claims centers in Alabama and Florida are helping customers file claims and get answers to their questions.
Can Allstate's Protection Services Turn Growth Into Higher Margins?
Allstate's Protection Services revenues rose 7.8% in Q2 2026, but declining earnings and rising claims costs challenge its path to stronger margins.
The Hidden Cost of Homeownership: Why Staying Loyal to Your Insurer Could Be an Expensive Mistake
Homeowners who stayed with their insurer last year paid a steep price for that loyalty, and the gap between those who shopped and those who didn't reveals something insurers would rather you not notice.
The Allstate Corporation (ALL) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Allstate (ALL). This makes it worthwhile to examine what the stock has in store.
5 Insurance Stocks Built to Keep Paying Dividends Through Hurricanes and Market Crashes
Hurricanes, market crashes, and rate shocks tend to destroy dividend streaks, but a handful of insurance stocks are engineered to keep paying through all three. The catch is that each one carries a specific vulnerability most income investors overlook.
Here's Why Allstate (ALL) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, AppFolio, Delek US Holdings, Flutter Entertainment, Honeywell Aerospace, Intuitive Surgical, Marvell, NetApp, and More
Stocks shattered records again Tuesday while oil surged, gold hit new highs, and crypto swung wildly, setting the stage for a fresh wave of analyst moves on names like Marvell, Intuitive Surgical, and NetApp that could reshape portfolios heading into the rest of the week.
What is the Auto Lab at Allstate Claims University? How Allstate trains auto claims adjusters on modern vehicle damage
Allstate's Auto Lab uses real vehicles, diagnostic technology and hands-on training to help claims adjusters identify hidden damage that may not be visible from the exterior, supporting more informed assessments and customer guidance Key takeaways: Allstate's Auto Lab features 22 vehicles and four motorcycles, including electric, hybrid and gas-powered models, allowing claims adjusters to gain hands-on experience with the vehicles and technologies customers drive today. The lab was designed using insights from more than 3.5 million auto claims to mirror the most common vehicle damage scenarios and repair challenges customers experience.
Allstate to hold Q3 2026 earnings call Nov. 5, 2026
NORTHBROOK, Ill., Oct. 5, 2026 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) announced the schedule for its third-quarter 2026 financial results and earnings conference call.
Allstate (ALL) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Allstate (ALL) concluded the recent trading session at $221.86, signifying a -1.58% move from its prior day's close.
Here's Why Allstate (ALL) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Allstate Offers A 7% Yielding Preferred Stock To Ride Out Earnings Decrease
The Allstate Corporation delivered robust Q2 2026 results, with EPS surging 61% YoY to $12.66 and strong net investment gains. ALL's catastrophe losses remain manageable, and preferred dividends are extremely well covered by net income, supporting fixed income appeal. The Series I preferred shares yield nearly 7% at current prices, offering an attractive risk/reward profile given ALL's balance sheet strength.
High Interest Rates Are Good News for These 4 Insurance Dividend Stocks
When Treasury yields sit near five-year highs, property and casualty insurers collect a quiet windfall that most income investors overlook entirely. Four dividend-raising giants are turning that structural tailwind into something much more durable than a rate-cycle trade.
QRG Capital Management Inc. Boosts Stock Position in The Allstate Corporation $ALL
QRG Capital Management Inc. increased its stake in shares of The Allstate Corporation (NYSE: ALL) by 82.1% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 94,687 shares of the insurance provider's stock after buying an additional 42,690 shares during the quarter.
Price Targets
Wells Fargo Upgrades Allstate (ALL) to Equal Weight
$236.00
(was $229.43)
Elyse Greenspan
·
Wells Fargo
Allstate price target lowered to $295 from $300 at Mizuho
$295.00
(was $224.27)
Mizuho Securities
Allstate price target lowered to $221 from $226 at Barclays
$221.00
(was $224.27)
Alex Scott
·
Barclays
Allstate upgraded to Buy from Hold at HSBC
$266.00
(was $224.27)
HSBC
Allstate price target lowered to $250 from $280 at Goldman Sachs
$250.00
(was $221.86)
Goldman Sachs
Allstate price target raised to $300 from $297 at Mizuho
$300.00
(was $252.21)
Mizuho Securities
Allstate price target lowered to $297 from $300 at Mizuho
$297.00
(was $257.21)
Mizuho Securities
Argus Downgrades Allstate (ALL) to Hold
$238.00
(was $257.62)
Kevin Heal
·
Argus Research
Allstate price target raised to $265 from $240 at Morgan Stanley
$265.00
(was $267.77)
Morgan Stanley
Allstate price target raised to $315 from $300 at Raymond James
$315.00
(was $266.31)
Raymond James
Allstate price target raised to $275 from $261 at UBS
$275.00
(was $271.07)
UBS
Allstate price target raised to $280 from $250 at Goldman Sachs
$280.00
(was $275.11)
Robert Cox
·
Goldman Sachs
Allstate downgraded to Underweight from Equal Weight at Wells Fargo
$250.00
(was $275.11)
Wells Fargo
Allstate price target raised to $300 from $275 at Roth Capital
$300.00
(was $264.59)
Roth Capital
Allstate price target raised to $226 from $213 at Barclays
$226.00
(was $264.59)
Alex Scott
·
Barclays
Allstate price target raised to $275 from $240 at Roth Capital
$275.00
(was $248.55)
Roth Capital
Allstate price target raised to $319 from $295 at BofA
$319.00
(was $240.55)
Atlantic Equities
Allstate downgraded to Neutral from Buy at UBS
$261.00
(was $250.35)
UBS
Allstate price target raised to $240 from $225 at Evercore ISI
$240.00
(was $250.59)
David Motemaden
·
Evercore ISI
Allstate price target raised to $242 from $236 at Cantor Fitzgerald
$242.00
(was $249.27)
Ryan Tunis
·
Cantor Fitzgerald